Nichi-Iko Pharmaceutical Co., Ltd. (TSE:4541) entered into an agreement to acquire Generics and Takayama Plane related Businesses from Teva Takeda Pharma Ltd. on July 30, 2020. The transaction will be structured in a way, that new target company will be established as a wholly owned subsidiary of Teva Takeda, which will be acquired by Nichi-Iko. The transaction has been approved by the Board of Directors of Nichi-Iko. The transaction is expected to close on February 1, 2021. Nichi-Iko Pharmaceutical Co., Ltd. (TSE:4541) completed the acquisition of Generics and Takayama Plane related Businesses from Teva Takeda Pharma Ltd. on February 1, 2021.